Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Its used on demand rather than daily, so cumulative exposure is limited compared with maintenance medications
These secondary patents are worth, collectively, several years of additional exclusivity billions of dollars of revenue protection
There was no reduction in hospitalization for heart failure in the LEADER trial
The dosing may differ slightly based on concentration and formulation
Measures of physical function also improved, with reductions in the WOMAC function subscale exceeding 70% for both retatrutide doses
Eli Lillys LillyDirect program offers Zepbound vials at reduced prices starting at $299-$449/month for self-pay patients
US$ 28.35
US$ 27.85
US$ 26.18
